170 related articles for article (PubMed ID: 5707735)
1. [Comparative antiarrhythmic and antitoxic activity of beta-hexamethyleneimino-para-butoxypropiophenone, novocaine amide and quinidine in arrhythmia, induced by calcium chlorides in mice].
Ammar EM
Farmakol Toksikol; 1968; 31(5):597-601. PubMed ID: 5707735
[No Abstract] [Full Text] [Related]
2. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
Ammar EM; Kudrin AN
Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
[No Abstract] [Full Text] [Related]
3. [Comparative antiarrhythmic activity of beta-N-hexamethyleneimino-P-butoxypropiophenone, quinidine and novocaine amide in aconitine auricular fibrillation and flutter in cats].
Ammar EM; Kudrin AN
Farmakol Toksikol; 1969; 32(4):415-8. PubMed ID: 5357458
[No Abstract] [Full Text] [Related]
4. [Antiarrhythmic activity of beta-aminoketones in comparison with quinidine and procaine amide in arrhythmia produced by calcium chloride in mice].
Iur'ev EG; Iur'eva TI
Farmakol Toksikol; 1973; 36(1):29-32. PubMed ID: 4685151
[No Abstract] [Full Text] [Related]
5. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
Samvelian VM; L'vov MV
Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
[No Abstract] [Full Text] [Related]
6. [Comparative evaluation of the antiarrhythmic effect of derivatives of diphenylacetic acid and novocaine amide].
Serdiuk EN; Koval'chuk LA
Farmakol Toksikol; 1971; 34(2):168-70. PubMed ID: 5563386
[No Abstract] [Full Text] [Related]
7. [Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].
Gorbunova VV; Gorbunov NP
Farmakol Toksikol; 1983; 46(3):48-50. PubMed ID: 6861988
[TBL] [Abstract][Full Text] [Related]
8. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
Bianchi C; Sanna GP; Turba C
Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
[No Abstract] [Full Text] [Related]
9. Ethyl-3-ethoxycarbonyl-4-hydroxy-2H-1,2-benzothiazine-2-acetate-1,1-dioxide, a compound producing ventricular arrhythmias.
Pruss TP
Toxicol Appl Pharmacol; 1969 Jan; 14(1):1-5. PubMed ID: 4180304
[No Abstract] [Full Text] [Related]
10. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
Igarashi T; Hashimoto N
Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
[No Abstract] [Full Text] [Related]
11. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
[TBL] [Abstract][Full Text] [Related]
12. Combined administration of quinidine with the beta-adrenolytic agent inderal and the local anaesthetic of the beta-aminoketone group, hexacaine, in various experimental models of arrhythmias.
Kudrin AN; Aslaniants ZK; Polevoi LG
Cor Vasa; 1975; 17(2):133-44. PubMed ID: 1157502
[TBL] [Abstract][Full Text] [Related]
13. [Antiarrhythmic effect of oxylidine].
Zaĭtseva KA; Mashkovskiĭ MD
Farmakol Toksikol; 1970; 33(3):305-9. PubMed ID: 4393832
[No Abstract] [Full Text] [Related]
14. [Metoclopramide and electrocardiographic changes caused by KC1, BaC12, CaC12, MgC12, aconitine, k-strophanthoside, vasopressin and by asphyxia].
Marmo E; Di Giacomo S; Imperatore A
Arzneimittelforschung; 1970 Jan; 20(1):12-8. PubMed ID: 4191693
[No Abstract] [Full Text] [Related]
15. Acute coronary care: a year's experience at Napier Hospital.
Langley RB; Wilson DF; Turner AS
N Z Med J; 1968 Apr; 67(431):477-9. PubMed ID: 5239791
[No Abstract] [Full Text] [Related]
16. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias].
Cosnier D; Grimal J; Duchene-Marullaz P
Therapie; 1971; 26(1):97-107. PubMed ID: 5554772
[No Abstract] [Full Text] [Related]
17. Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice.
Ferrini R; Miragoli G
Arzneimittelforschung; 1979; 29(9a):1473-4. PubMed ID: 575496
[TBL] [Abstract][Full Text] [Related]
18. Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugs.
Podrid PJ; Lown B; Graboys TB; Lampert S
Circulation; 1986 Feb; 73(2 Pt 2):II81-91. PubMed ID: 3943177
[No Abstract] [Full Text] [Related]
19. Comparative effectiveness of lignocaine, quinidine, propranolol and procainamide as antifibrillatory agents.
Murnaghan MF
Br J Pharmacol; 1970 Sep; 40(1):149P. PubMed ID: 5487011
[No Abstract] [Full Text] [Related]
20. Studies with quinidine and digoxin on the cardiac vulnerable period.
McCawley EL; Dick HL; Reeves M
Proc West Pharmacol Soc; 1966; 9():9-12. PubMed ID: 5958505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
